Literature DB >> 1299205

Afterdepolarizations and triggered activity.

H A Fozzard1.   

Abstract

One of the possible cellular mechanisms for certain types of ventricular arrhythmias is afterdepolarizations. There are two types of afterdepolarization. The delayed afterdepolarization (DAD) arises from the resting potential after full repolarization of an action potential and it may reach threshold for activation. It is favored by cellular Ca overload, and rapid preceding activation rates. The inward current generating the DAD is caused by one of two mechanisms: a Ca-dependent opening of non-specific cation channels, or Ca activation of a rheogenic Na/Ca exchange. The early afterdepolarization (EAD) arises on the shoulder of a preceding action potential plateau and it is favored by slow preceding activation rate and prolonged action potentials. Ca channels are usually responsible for the inward current for EAD's, and cellular Ca overload is not related. These afterdepolarizations have characteristics that suggest their etiological role in certain arrhythmias found in heart failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299205     DOI: 10.1007/978-3-642-72477-0_10

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  25 in total

1.  Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.

Authors:  Emiliano Horacio Medei; José H M Nascimento; Roberto C Pedrosa; Luciane Barcellos; Masako O Masuda; Serge Sicouri; Marcelo V Elizari; Antonio C Campos de Carvalho
Journal:  Europace       Date:  2008-05-30       Impact factor: 5.214

2.  Stretch current-induced abnormal impulses in CaMKIIδ knockout mouse ventricular myocytes.

Authors:  Dongwu Lai; Lin Xu; Jun Cheng; Arnaud B Guilbert; Hyun Joung Lim; Guosheng Fu; Yanggan Wang
Journal:  J Cardiovasc Electrophysiol       Date:  2012-12-21

3.  Pharmacological blockade of small conductance Ca2+-activated K+ channels by ICA reduces arrhythmic load in rats with acute myocardial infarction.

Authors:  Laura A Hundahl; Stefan M Sattler; Lasse Skibsbye; Jonas G Diness; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Pflugers Arch       Date:  2017-03-11       Impact factor: 3.657

Review 4.  MicroRNA regulation of cardiac conduction and arrhythmias.

Authors:  Gene H Kim
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

Review 5.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

6.  A Mathematical Model of the Human Cardiac Na+ Channel.

Authors:  Tesfaye Negash Asfaw; Vladimir E Bondarenko
Journal:  J Membr Biol       Date:  2019-01-14       Impact factor: 1.843

Review 7.  Cardiac electrical remodeling in health and disease.

Authors:  Michael J Cutler; Darwin Jeyaraj; David S Rosenbaum
Journal:  Trends Pharmacol Sci       Date:  2011-03       Impact factor: 14.819

8.  Persistent increases in Ca(2+) influx through Cav1.2 shortens action potential and causes Ca(2+) overload-induced afterdepolarizations and arrhythmias.

Authors:  Xiaoying Zhang; Xiaojie Ai; Hiroyuki Nakayama; Biyi Chen; David M Harris; Mingxin Tang; Yuping Xie; Christopher Szeto; Yingxin Li; Ying Li; Hongyu Zhang; Andrea D Eckhart; Walter J Koch; Jeffery D Molkentin; Xiongwen Chen
Journal:  Basic Res Cardiol       Date:  2015-11-26       Impact factor: 17.165

Review 9.  Caveolae, ion channels and cardiac arrhythmias.

Authors:  Ravi C Balijepalli; Timothy J Kamp
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

10.  Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations.

Authors:  Mitsunori Maruyama; Jianmin Xiao; Qiang Zhou; Kannan Vembaiyan; Su-Kiat Chua; Michael Rubart-von der Lohe; Shien-Fong Lin; Thomas G Back; S R Wayne Chen; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-09-14       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.